Works matching IS 2160763X AND DT 2024 AND VI 13 AND IP 4

Results: 13

Cardiovascular Evaluation of Etrasimod, a Selective Sphingosine 1‐phosphate Receptor Modulator, in Healthy Adults: Results of a Randomized, Thorough QT/QTc Study.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 4, p. 326, doi. 10.1002/cpdd.1388

By:

Darpo, Borje;
Connor, Kalvin;
Cabell, Christopher H.;
Grundy, John S.

Publication type:

Article

Physiologically Based Pharmacokinetic Absorption Model for Pexidartinib to Evaluate the Impact of Meal Contents and Intake Timing on Drug Exposure.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 4, p. 440, doi. 10.1002/cpdd.1385

By:

Nakayama, Shintaro;
Lukacova, Viera;
Tanabe, Shuichi;
Watanabe, Akiko;
Mullin, Jim;
Suarez‐Sharp, Sandra;
Shimizu, Takako

Publication type:

Article

Pharmacokinetics and Pharmacodynamics of Etripamil, an Intranasally Administered, Fast‐Acting, Nondihydropyridine Calcium Channel Blocker.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 4, p. 367, doi. 10.1002/cpdd.1383

By:

Ip, James E.;
Wight, Douglas;
Yue, Corinne Seng;
Nguyen, David;
Plat, Francis;
Stambler, Bruce S.

Publication type:

Article

Pharmacokinetics, Bioequivalence, and Safety Evaluation of Two Oral Formulations of Calcium Dobesilate Capsules in Healthy Chinese Volunteers Under Fasting and Fed Conditions.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 4, p. 360, doi. 10.1002/cpdd.1376

By:

Wang, Yanrong;
Liu, Ying;
Tang, Liyuan;
Gao, Jie;
LI, Hongmin;
Dai, Xinya;
Chen, Ran;
Wang, Fengqin

Publication type:

Article

Results from a Phase 1 Study Assessing the Pharmacokinetics of the Aldosterone Synthase Inhibitor Baxdrostat in Participants with Varying Degrees of Renal Function.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 4, p. 410, doi. 10.1002/cpdd.1371

By:

Freeman, Mason W.;
Halvorsen, Yuan‐Di;
Bond, Mary;
Murphy, Brian;
Isaacsohn, Jonathan

Publication type:

Article

Safety, Tolerability, and Pharmacokinetics of Voriconazole for Injection in Two Preparations in Chinese Healthy Adult Volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 4, p. 404, doi. 10.1002/cpdd.1370

By:

Yu, Jin;
Wu, Yi;
Lin, Sisi;
Wang, Ying

Publication type:

Article

Population Pharmacokinetic and Pharmacodynamic Modeling of Romiplostim Biosimilar GP40141 and Reference Product in Healthy Volunteers to Evaluate Biosimilarity.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 4, p. 419, doi. 10.1002/cpdd.1367

By:

Makarenko, Igor;
Petrov, Aleksandr;
Belova, Bella;
Saparova, Valeria;
Arefeva, Anna;
Peskov, Kirill;
Kudryashova, Nataliya;
Khokhlov, Alexandr;
Drai, Roman

Publication type:

Article

Reduced Plasma Levodopa Fluctuations with More Frequent Administration of a Novel Carbidopa/Levodopa Functionally Scored Tablet.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 4, p. 380, doi. 10.1002/cpdd.1360

By:

Chase, Thomas N.;
AL‐Sabbagh, Ahmad;
Koga, Minako;
Clarence‐Smith, Kathleen

Publication type:

Article

Mass Balance and Metabolite Profile after Single and Multiple Oral Doses of Pritelivir in Healthy Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 4, p. 389, doi. 10.1002/cpdd.1358

By:

Bonsmann, Susanne;
McCormick, David;
Pausch, Jörg;
de Vries, Michiel;
Sumner, Melanie;
Birkmann, Alexander;
Zimmermann, Holger;
Kropeit, Dirk

Publication type:

Article

Safety, Tolerability, and Pharmacokinetics of a Novel Oral Phosphodiesterase 4 Inhibitor, ME3183: First‐in‐Human Phase 1 Study.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 4, p. 341, doi. 10.1002/cpdd.1351

By:

Kato, Seiji;
Cho, Naoki;
Koresawa, Tomokazu;
Otake, Kazunari;
Kano, Akiko

Publication type:

Article

A Randomized, Single‐Dose, Parallel‐Controlled Phase 1 Clinical Comparison of an Omalizumab Biosimilar Candidate with Reference Omalizumab in Healthy Chinese Male Volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 4, p. 349, doi. 10.1002/cpdd.1350

By:

Cheng, Jie;
Wang, Chenguang;
Xu, Jin;
Zhao, Chunyang;
Song, Rong;
Wang, Yijun;
Zou, Yang;
Zhang, Xunmin;
Shan, Yong;
Zhou, Jian;
Jia, Jing‐Ying

Publication type:

Article

Bioequivalence of 240 mg Apalutamide Tablets and Preparation in Aqueous Food Vehicles for Alternative Administration.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 4, p. 432, doi. 10.1002/cpdd.1346

By:

Yu, Alex;
Van Uffel, Mieke;
Jiao, Juhui J.;
Rosales, Rosamerlinda;
Erba, Maura;
Haddish‐Berhane, Nahor

Publication type:

Article

Issue Information.

Published in:: Clinical Pharmacology in Drug Development, 2024, v. 13, n. 4, p. 321, doi. 10.1002/cpdd.1117
Publication type:: Article